Danaher Corporation

DHR Healthcare Diagnostics & Research

Danaher Corporation’s revenue for fiscal 2025 (year ended December 2025) was $24.6 billion, up 2.90% from fiscal 2024. In the quarter to June 2026, revenue grew 5.54%, EPS grew 59.7%, free cash flow grew 15.6% and total debt rose 49.2%, each against the same quarter a year earlier. Member of the S&P 500.

228.97 2.53 −1.09%
Market cap
$162.7B
P/E
40.5×
Fwd P/E
29.2×
Dividend yield
0.66%
F-score
6/9
Altman Z
4.52
Beneish M
−2.57
Dividend safety
69/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

40.63 45.15 36.53 33.71
P/S ratio
5.81 6.64 5.42 5.35
P/FCF ratio
28.02 30.82 25.24 24.48
P/Operating CF
84.78 77.07 101.53 87.58
P/B ratio
2.76 3.11 2.53 2.55
Price to Tangible BV
0.00 0.00 0.00 0.00
EV/Sales
6.44 7.20 5.90 6.18
EV/EBITDA
22.21 24.79 20.17 20.14
EV/Operating CF
24.72 27.58 22.69 23.38
EV/FCF
31.07 33.43 27.47 28.26
Quick Ratio
0.84 1.25 1.28 1.03
Current Ratio
1.52 1.87 1.87 1.65
Net Debt/EBITDA
8.62 6.49 6.02 11.35
Debt/Assets
21.07% 22.06% 21.02% 27.23%
Debt/Equity
0.33 0.35 0.33 0.48
Asset Turnover
0.30 0.31 0.30 0.29
Operating CF/Net income
1.83 1.77 1.28 1.76
Capex/Depreciation
(0.47) (0.56) (0.38) (0.38)
Interest Coverage
17.22 27.31 21.33 10.53
Research and Development Expense of Revenue
6.24% 6.41% 6.50% 6.58%
Selling, General and Administrative Expense of Revenue
32.89% 29.63% 31.26% 33.07%
Intangible Assets out of Total Assets
0.76 0.73 0.72 0.74
Share Based Compensation of Revenue
1.37% 0.92% 0.97% 1.48%
Graham Net Nets
(0.14) (0.11) (0.12) (0.20)
Graham Number
88.83 91.70 93.47 97.36
Earnings Yield
2.46% 2.21% 2.74% 2.97%
Free Cash Flow Yield
3.57% 3.24% 3.96% 4.09%
Revenue per Share
8.52 9.59 8.41 8.88
Operating CF per Share
2.34 2.97 1.87 2.18
Capex per Share
(0.41) (0.49) (0.33) (0.38)
Free Cash Flow per Share
1.93 2.48 1.53 1.79
Cash per Share
2.15 6.48 8.05 6.16
Shareholders Equity per Share
71.87 73.72 74.81 74.57
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
71.87 73.72 74.81 74.57
Free Cash Flow
1,370.00 1,769.00 1,085.00 1,265.00
Working Capital
3,282.00 5,949.00 6,475.00 5,276.00
Capital Expenditures
(292.00) (348.00) (237.00) (269.00)
Net Current Asset Value
(19,211.00) (18,167.00) (16,652.00) (26,394.00)
EV/EBIT
33.86 37.73 30.69 30.26
Capex to Sales
0.05 0.05 0.04 0.04
Price to Operating Income
30.54 34.79 28.20 26.20
Other line items
Average Receivables
3,631.00 3,725.00 3,662.50 3,764.50
Average Payables
1,647.00 1,798.50 1,756.00 1,773.50
Average Inventory
2,676.00 2,409.50 2,570.00 2,974.50
Average Assets
80,256.00 80,503.00 81,330.00 86,993.50
Average Common Equity
51,192.50 51,045.50 51,907.00 52,467.00

Fold the line items

Columns are period end dates